Insitro

Insitro

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.insitro.com

Last Round

Series C

3/15/2021

Total Funding Raised

$643M

Momentum Score

25 /100

Company Overview

insitro is a biotechnology company focused on data-driven drug discovery and development that leverages machine learning and high-throughput biology to enhance pharmaceutical R&D and accelerate the creation of effective therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformmachine learning drug discoverytechbioAI biotechhigh-throughput biologydrug target identificationin silico drug discoverypredictive disease modelscomputational biologytherapeutic programsproprietary biological datadrug R&D accelerationfull stack AI platformmodality-agnostic AITherML Platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insitro Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Insitro Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C3/15/2021
Series B5/26/2020
Series A4/16/2019

Key People

Founding team and executive leadership

Daphne Koller

Founder And CEO

Founding Team

Insitro Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries A, Series C, Series B
CPP InvestmentsSeries B, Series C
SoftBank Investment AdvisersSeries C
TemasekSeries C
GVSeries A, Series B, Series C
ARCH Venture PartnersSeries C
Bezos ExpeditionsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Launched Virtual Human, a genetically anchored causal AI engine for disease research.

  • Mar 23, 2026

    Collaboration with Bristol Myers Squibb broadened for ALS therapeutic programs.

Insitro Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insitro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Insitro's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range250
Year Founded2018
Last Funding3/15/2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.